VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Experimental Cell Research

• Publication date

  2001-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/EXCR.2000.5102PMID 11161716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The PI 3-kinase isoforms p110(alpha) and p110(beta) have differential roles in PDGF- and insulin-mediated signaling.

  2000cited by this paper
• Vascular endothelial growth factor: molecular and biological aspects.

  1999cited by this paper
• Requirement of Phosphatidylinositol 3-Kinase in Focal Adhesion Kinase-promoted Cell Migration*

  1999cited by this paper
• Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I.

  1999cited by this paper
• Shaping up for shipping out: PLCgamma signaling of morphology changes in EGF-stimulated fibroblast migration.

  1999cited by this paper
• Tyrosine Phosphatase SHP-2 Is Involved in Regulation of Platelet-derived Growth Factor-induced Migration*

  1999cited by this paper
• Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor‐2

  1999cited by this paper
• The Role of Phosphoinositide 3-Kinase Lipid Products in Cell Function*

  1999cited by this paper
• The Role of Phosphatidylinositol 3-Kinase in Vascular Endothelial Growth Factor Signaling*

  1999cited by this paper
• Apoptosis: Akt is more than just a Bad kinase

  1999cited by this paper
• Roles of Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase Pathways in Stimulation of Vascular Smooth Muscle Cell Migration and Deoxyriboncleic Acid Synthesis by Insulin-Like Growth Factor-I1.

  1999cited by this paper
• Focal adhesion kinase in integrin-mediated signaling.

  1999cited by this paper
• Structure and function of vascular endothelial growth factor receptor-1 and -2.

  1999cited by this paper
• Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.

  1998cited by this paper
• Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway

  1998cited by this paper
• Insulin-like growth factor I stimulates tyrosine phosphorylation of p130(Cas), focal adhesion kinase, and paxillin. Role of phosphatidylinositol 3'-kinase and formation of a p130(Cas).Crk complex.

  1998cited by this paper
• Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF.

  1997cited by this paper
• Activation of HER4 by heparin‐binding EGF‐like growth factor stimulates chemotaxis but not proliferation

  1997cited by this paper
• Vascular endothelial growth factor and its receptors in normal human testicular tissue.

  1997cited by this paper
• Signaling Mechanisms in Growth Factor‐Stimulated Cell Motility

  1997cited by this paper
• αvβ3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF

  1997cited by this paper
• Requirement for Phosphatidylinositol 3′-Kinase Activity in Platelet-derived Growth Factor-stimulated Tyrosine Phosphorylation of p125 Focal Adhesion Kinase and Paxillin (*)

  1996cited by this paper
• Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

  1995cited by this paper
• Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

  1995cited by this paper
• Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice

  1995cited by this paper
• Platelet-derived growth factor modulation of focal adhesion kinase (p125FAK) and paxillin tyrosine phosphorylation in Swiss 3T3 cells. Bell-shaped dose response and cross-talk with bombesin.

  1994cited by this paper
• Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.

  1994cited by this paper
• Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells.

  1994cited by this paper
• Expression of protein tyrosine kinases in islet cells: possible role of the Flk-1 receptor for beta-cell maturation from duct cells.

  1994cited by this paper
• Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src

  1994cited by this paper
• Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 3' kinase.

  1994cited by this paper
• Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling.

  1994cited by this paper
• PDGF alpha‐ and beta‐receptors activate unique and common signal transduction pathways.

  1992cited by this paper
• The small GTP-binding protein rac regulates growth factor-induced membrane ruffling.

  1992cited by this paper
• Identification of a hydrophobic region in the carboxyl terminus of the platelet-derived growth factor beta-receptor which is important for ligand-mediated endocytosis.

  1991cited by this paper
• Assays for angiogenesis: a review.

  1991cited by this paper

• Predictive Value of Serum VEGF Levels in Non-Small Cell Lung Cancer: A Review

  2025cites this paper
• MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities

  2024cites this paper
• Vascular endothelial cell morphology and alignment regulate VEGF‐induced endothelial nitric oxide synthase activation

  2024cites this paper
• Lactic acid fermented Elaeagnus multiflora Thunb. fruit: suppressive effect of its extracts on angiogenesis

  2024cites this paper
• Surface charge, but not size, of liposomes is involved in the suppression of rat basophilic leukemia (RBL‐2H3) cell degranulation mediated by Akt phosphorylation

  2024cites this paper
• Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies

  2024cites this paper
• Muscone abrogates breast cancer progression through tumor angiogenic suppression via VEGF/PI3K/Akt/MAPK signaling pathways

  2024cites this paper
• The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy

  2022cites this paper
• Focal adhesion kinase-mediated signaling controls the onset of pancreatic cell differentiation

  2022cites this paper
• Dihydroartemisinin inhibits endothelial cell migration via the TGF-β1/ALK5/SMAD2 signaling pathway

  2021cites this paper
• OMICs based identification of the mechanisms that underpin FAK’s regulation of gene expression

  2020cites this paper
• Association of Low Tumor Endothelial Cell pY397–Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer

  2020cites this paper
• Focal Adhesion Kinase in Ovarian Cancer: A Potential Therapeutic Target for Platinum and Taxane-Resistant Tumors.

  2019cites this paper
• INVESTIGATING THE MOLECULAR REGULATION OF ANGIOGENESIS IN THE HEART

  2019cites this paper
• Triple‐tyrosine kinase inhibition attenuates pulmonary arterial hypertension and neointimal formation

  2019cites this paper
• Semaphorin 7A Promotes VEGFA/VEGFR2-Mediated Angiogenesis and Intraplaque Neovascularization in ApoE-/- Mice

  2018cites this paper
• The role of the proteoglycans OMD and PRELP in the maintenance of brain vasculature

  2018influential citation
• Formyl Peptide Receptor 1 Modulates Endothelial Cell Functions by NADPH Oxidase-Dependent VEGFR2 Transactivation

  2018cites this paper
• Acetyl-l-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways.

  2018cites this paper
• Nuclear FAK and its kinase activity regulate VEGFR2 transcription in angiogenesis of adult mice

  2018cites this paper
• Investigations of FAK inhibitors: a combination of 3D-QSAR, docking, and molecular dynamics simulations studies

  2018cites this paper
• Vascular Endothelial Growth Factor-A Exerts Diverse Cellular Effects via Small G Proteins, Rho and Rap

  2018cites this paper
• Improved in vitro angiogenic behavior on anodized titanium dioxide nanotubes

  2017influential citation
• Regulation of Gap Junction Internalization and Degradation

  2017cites this paper
• A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling

  2017cites this paper
• Antiangiogenic properties of caudatin in vitro and in vivo by suppression of VEGF-VEGFR2-AKT/FAK signal axis

  2017cites this paper
• The structure and functions of paxillin and its roles in neovascularization.

  2017cites this paper
• Predicting angiogenic receptor trafficking and signaling via computational systems biology

  2016cites this paper
• Targeting Tumor Angiogenesis for Cancer Prevention

  2016cites this paper
• The novel model peptide, αAL14, regulates angiogenesis by inhibiting VEGFR 2-mediated signaling in HUVECs.

  2016cites this paper
• The effects of green tea and pomegranate polyphenols on in vitro and in vivo VEGF activity

  2016cites this paper
• Marine Sponge-Derived Antiangiogenic Compounds for Cancer Therapeutics

  2016cites this paper
• Marine Sponge Derived Antiangiogenic Compounds

  2015cites this paper
• Connexin43 phosphorylation by PKC and MAPK signals VEGF-mediated gap junction internalization

  2015cites this paper
• Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumors

  2015influential citation
• Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3-[(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas: Discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitors.

  2015cites this paper
• Emerging Roles of Focal Adhesion Kinase in Cancer

  2015cites this paper
• VEGF : un biomarqueur potentiel dans la physiopathologie cardiovasculaire

  2015cites this paper
• Shear Stress Induces Differentiation of Endothelial Lineage Cells to Protect Neonatal Brain from Hypoxic-Ischemic Injury through NRP1 and VEGFR2 Signaling

  2015cites this paper
• Vascular Endothelial Growth Factor-A-Induced Vascular Permeability and Leukocyte Extravasation

  2015cites this paper
• Application of stem cell/growth factor system, as a multimodal therapy approach in regenerative medicine to improve cell therapy yields.

  2014cites this paper
• Jaceosidin, a natural flavone, promotes angiogenesis via activation of VEGFR2/FAK/PI3K/AKT/NF-κB signaling pathways in endothelial cells

  2014influential citation
• NSK-01105, a Novel Sorafenib Derivative, Inhibits Human Prostate Tumor Growth via Suppression of VEGFR2/EGFR-Mediated Angiogenesis

  2014influential citation
• Glycated collagen and altered glucose increase endothelial cell adhesion strength

  2013cites this paper
• Brucine, an indole alkaloid from Strychnos nux-vomica attenuates VEGF-induced angiogenesis via inhibiting VEGFR2 signaling pathway in vitro and in vivo.

  2013cites this paper
• FAK-heterozygous mice display enhanced tumour angiogenesis

  2013cites this paper
• Dynamics of focal adhesions and reorganization of F‐actin in VEGF‐stimulated NSCs under varying differentiation states

  2013cites this paper
• VEGFA and tumour angiogenesis

  2013cites this paper
• Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2–mediated angiogenesis

  2013influential citation
• Rôle des microarns dans la régulation de la voie pro-migratoire p38 activée par le VEGF

  2012cites this paper
• Quercetin-4′-O-β-D-glucopyranoside (QODG) Inhibits Angiogenesis by Suppressing VEGFR2-Mediated Signaling in Zebrafish and Endothelial Cells

  2012influential citation
• Tissue-level Mechanisms Driving Cardiac Progenitor and Extracellular Matrix Movements during Early Vertebrate Heart Development

  2012cites this paper
• Angiogenesis and hypertension: the dual role of anti-hypertensive and anti-angiogenic therapies.

  2012cites this paper
• Targeted Inhibition of Multiple Proinflammatory Signalling Pathways for the Prevention and Treatment of Multiple Myeloma

  2012cites this paper
• Focal adhesion kinase and tumour angiogenesis

  2012cites this paper
• Focal adhesion kinase and endothelial cell apoptosis.

  2012cites this paper
• Functional characterization of the PlGF-2 heparin-binding domain

  2011cites this paper
• Focal adhesion kinase: from in vitro studies to functional analyses in vivo.

  2011cites this paper
• VEGF-mediated PI3K class IA and PKC signaling in cardiomyogenesis and vasculogenesis of mouse embryonic stem cells

  2011cites this paper
• Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapy.

  2011cites this paper
• Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis.

  2011cites this paper
• Nanoparticle delivery of siRNA for cancer therapy

  2010cites this paper
• Endothelial Dysfunction and Inflammation

  2010cites this paper
• Dissecting TNF-TNFR1/TNFR2 signaling pathways in vasculature

  2010cites this paper
• VEGF and PDGF Receptors: Biologic Relevance and Clinical Approaches to Inhibition

  2009cites this paper
• Signal transduction by focal adhesion kinase in cancer

  2009influential citation
• Thromboembolic events in patients treated with anti-angiogenic drugs.

  2009cites this paper
• The role of PI-3 kinase in cancer biology and approaches to the therapeutics of cancer

  2009cites this paper
• Molecular Diversity of VEGF‐A as a Regulator of Its Biological Activity

  2009cites this paper
• Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway.

  2009cites this paper
• Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways

  2009cites this paper
• FERM control of FAK function: Implications for cancer therapy

  2008cites this paper
• Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy

  2008cites this paper
• Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.

  2008cites this paper
• Integrin and Growth Factor Receptor Alliance in Angiogenesis

  2008cites this paper
• VEGF Signal Tranduction in Angiogenesis

  2008cites this paper
• Signalisation et implication de BMP-7 dans l'invasion cellulaire et la carcinogenèse colique

  2007cites this paper
• Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: Role of the Eph receptors

  2007cites this paper
• Cytoskeletal signaling proteins; complex regulatory mechanisms and roles in innate immunity

  2007cites this paper
• Pharmacological strategies to interfere with proinflammatory signal transduction in endothelial cells

  2007cites this paper
• Uterine cervical neoplasia : aspects of biology and pathology

  2007cites this paper
• Early pancreas development and endocrine induction : PTF1a and VEGF.

  2007cites this paper
• Caractérisation des éléments de couplage moléculaire entre le récepteur-2 du VEGF et la MAP kinase SAPK2/p38 dans les cellules endothéliales

  2007cites this paper
• Reactive Oxygen Species and Angiogenesis

  2007cites this paper
• Endothelial cell migration during angiogenesis.

  2007cites this paper
• Targeting vascular cell migration as a strategy for blocking angiogenesis: the central role of focal adhesion protein tyrosine kinase family.

  2007cites this paper
• 3.10 – Signaling Chains

  2007cites this paper
• Actin Remodeling at the Heart of Endothelial Cell Migration : An Overview

  2007cites this paper
• Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS.

  2006cites this paper
• VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: Implications for vasculogenic mimicry

  2006cites this paper
• Mécanismes régulant l'activation et les fonctions de la kinase d'adhérence focale (FAK) en réponse au Vascular endothelial growth factor (VEGF) dans les cellules endotheliales

  2006cites this paper
• Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation

  2006cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 192 Molecular Mechanisms of Action of Histidine-rich Glycoprotein in Angiogenesis Inhibition

  2006cites this paper
• Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis.

  2006cites this paper
• Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesis

  2005cites this paper
• The impact of cigarette smoke on cell survival and inflammation in rat lungs : the role of oxidative stress and VEGF/KDR signalling and its implications in COPD

  2005cites this paper
• Angiogenesis and hematological malignancies

  2005cites this paper
• VEGF receptor‐2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis

  2005cites this paper
• Loss of E‐cadherin mediated cell–cell adhesion as an early trigger of apoptosis induced by photodynamic treatment

  2005cites this paper
• Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF)

  2005cites this paper